International Journal of Chronic Obstructive Pulmonary Disease

Scope & Guideline

Fostering Global Collaboration in COPD Research

Introduction

Welcome to the International Journal of Chronic Obstructive Pulmonary Disease information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of International Journal of Chronic Obstructive Pulmonary Disease, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageEnglish
ISSN1178-2005
PublisherDOVE MEDICAL PRESS LTD
Support Open AccessYes
CountryNew Zealand
TypeJournal
Convergefrom 2006 to 2024
AbbreviationINT J CHRONIC OBSTR / Int. J. Chronic Obstr. Pulm. Dis.
Frequency1 issue/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressPO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND

Aims and Scopes

The International Journal of Chronic Obstructive Pulmonary Disease primarily focuses on advancing research related to chronic obstructive pulmonary disease (COPD), with a strong emphasis on clinical studies, epidemiology, and innovative therapeutic approaches.
  1. Clinical Management and Treatment Strategies:
    The journal publishes studies that explore various management strategies for COPD, including pharmacological treatments, inhalation therapies, and non-pharmacological interventions such as pulmonary rehabilitation.
  2. Epidemiology and Risk Factors:
    Research focusing on the prevalence, risk factors, and comorbidities associated with COPD is a key area of interest, providing valuable insights into the disease's impact on diverse populations.
  3. Pathophysiology and Mechanisms:
    The journal emphasizes studies that investigate the underlying mechanisms of COPD, including inflammatory pathways, genetic factors, and the role of the microbiome in disease progression.
  4. Quality of Life and Patient-Centered Approaches:
    Articles addressing the quality of life in COPD patients, including psychological aspects such as anxiety and depression, and the effectiveness of patient education and self-management strategies are commonly featured.
  5. Innovative Technologies and Interventions:
    The journal is open to research on new technologies, such as telemedicine, digital health solutions, and novel pharmacological agents that aim to improve patient outcomes and disease management.
Recent publications in the International Journal of Chronic Obstructive Pulmonary Disease indicate several emerging themes that are gaining traction within the field.
  1. Integration of Digital Health Solutions:
    The rise of digital health technologies, including telehealth and mobile health applications, is becoming a central theme, reflecting a shift towards remote monitoring and management of COPD.
  2. Comorbidity Research:
    There is an increasing focus on the interplay between COPD and other chronic conditions, such as cardiovascular diseases and metabolic syndromes, highlighting the importance of integrated care approaches.
  3. Patient-Centered Outcomes and Quality of Life:
    Research emphasizing patient-reported outcomes, quality of life assessments, and psychosocial factors in COPD management is trending, indicating a growing recognition of the holistic nature of care.
  4. Biomarkers and Personalized Medicine:
    Studies exploring biomarkers for diagnosis, prognosis, and treatment responses are on the rise, representing a shift towards personalized medicine approaches in COPD management.
  5. Environmental and Lifestyle Factors:
    Emerging research is increasingly addressing the impact of environmental exposures, dietary habits, and lifestyle modifications on COPD development and management.

Declining or Waning

As the field of COPD research evolves, certain themes have shown a decline in focus within the journal's recent publications.
  1. Traditional Pharmacological Therapies:
    There has been a noticeable reduction in studies focused solely on traditional pharmacological therapies, such as oral corticosteroids, as newer therapeutic approaches gain prominence.
  2. Surgery and Invasive Procedures:
    Research related to surgical interventions for COPD, such as lung volume reduction surgery, appears to have decreased, likely due to a growing preference for less invasive management options.
  3. Basic Science Research:
    While fundamental research into COPD pathophysiology remains important, the journal has seen fewer basic science studies compared to clinical and translational research, reflecting a shift towards more applied investigations.

Similar Journals

Indian Journal of Respiratory Care

Empowering Knowledge in Respiratory Care
Publisher: JAYPEE BROTHERS MEDICAL PUBLISHERS PVT LTDISSN: 2277-9019Frequency: 4 issues/year

Welcome to the Indian Journal of Respiratory Care, a premier platform dedicated to advancing research and clinical practices in the field of respiratory health. Published by JAYPEE BROTHERS MEDICAL PUBLISHERS PVT LTD, this journal has established itself as a crucial resource for researchers, healthcare professionals, and educators since embracing an Open Access model in 2012, ensuring maximum visibility and accessibility of vital research findings. The journal aims to disseminate high-quality articles encompassing a wide range of topics, including but not limited to, respiratory diseases, pulmonary care, and innovative treatment approaches. With its commitment to fostering collaboration and knowledge exchange, the Indian Journal of Respiratory Care is poised to make a significant impact in the ever-evolving landscape of respiratory medicine. As the field continues to grow, this journal serves as an essential touchpoint for those invested in enhancing patient care and outcomes.

Chronic Respiratory Disease

Driving excellence in respiratory disease research.
Publisher: SAGE PUBLICATIONS LTDISSN: 1479-9723Frequency: 1 issue/year

Chronic Respiratory Disease is a leading peer-reviewed journal dedicated to advancing the field of pulmonary and respiratory medicine. Published by SAGE Publications Ltd since its inception in 2004, this open-access journal has been at the forefront of disseminating high-quality research aimed at addressing chronic respiratory conditions. With an impressive impact factor and classified as Q1 in the 2023 category of Pulmonary and Respiratory Medicine, it ranks an admirable #45 out of 155 in Scopus, placing it in the 71st percentile of its field. This journal features a diverse range of studies, reviews, and clinical insights that cater to researchers, healthcare professionals, and students alike, encouraging the exchange of innovative ideas and practices in respiratory disease management. Operating out of London, UK, Chronic Respiratory Disease exemplifies a commitment to openness, having transitioned to open access since 2017, thereby ensuring that pivotal research is readily accessible to a global audience engaged in the improvement of respiratory health.

Pulmonary Medicine

Empowering Clinicians with Cutting-edge Insights
Publisher: HINDAWI LTDISSN: 2090-1836Frequency: 1 issue/year

Pulmonary Medicine, published by HINDAWI LTD, stands as a prestigious open-access journal since 2010, dedicated to advancing the field of pulmonary and respiratory medicine. Located in Egypt, this journal is indexed with an ISSN of 2090-1836 and an E-ISSN of 2090-1844, and it has attained a commendable Q2 ranking in both the miscellaneous medicine and pulmonary health categories, indicative of its significant impact and quality. With an impressive Scopus ranking of #15 out of 155 in the pulmonary and respiratory medicine category, the journal is positioned in the 90th percentile, highlighting its relevance and contribution to ongoing research. The journal aims to publish high-quality original research, reviews, and clinical studies that address pressing issues in pulmonary health, making it a vital resource for researchers, clinicians, and students seeking to enhance their understanding and practice in respiratory medicine. By embracing an open-access model, Pulmonary Medicine provides a platform for disseminating knowledge, fostering collaboration, and driving innovation within the global scientific community.

Chronic Obstructive Pulmonary Diseases-Journal of the COPD Foundation

Connecting professionals with groundbreaking COPD studies.
Publisher: COPD FOUNDATIONISSN: 2372-952XFrequency: 4 issues/year

Chronic Obstructive Pulmonary Diseases - Journal of the COPD Foundation, published by the esteemed COPD Foundation, serves as a vital platform for advancing research in the field of pulmonary and respiratory medicine. With an ISSN of 2372-952X, this journal emphasizes the exploration and dissemination of knowledge related to chronic obstructive pulmonary disease (COPD) while addressing broader topics in respiratory health. Recognized within the Q2 category of the 2023 *Scopus* rankings and positioned at the 47th percentile in its field, the journal showcases innovative studies, clinical insights, and evidence-based practices crucial for professionals, researchers, and students alike. Although operating as a traditional publication, it seeks to provide immediate access to groundbreaking research on the prevention and management of COPD, facilitating improved patient outcomes. As it continues to expand its influence since its convergence in 2018, this journal is dedicated to bridging gaps in pulmonary medicine, making it an indispensable resource for the global respiratory health community.

BMC Pulmonary Medicine

Connecting researchers and practitioners for impactful insights.
Publisher: BMCISSN: 1471-2466Frequency: 1 issue/year

BMC Pulmonary Medicine is a leading open access journal dedicated to the field of pulmonary and respiratory medicine, published by BMC since its inception in 2001. With an ISSN of 1471-2466, this journal plays a pivotal role in advancing knowledge and research dissemination in its field, maintaining a prominent position with a 2023 Scopus ranking of #65 out of 155 journals, placing it within the 58th percentile of the category. Based in the United Kingdom, it operates under a collaborative mission to provide unrestricted access to vital research, contributing to the global understanding of respiratory health issues. The journal is recognized for its commitment to high-quality, peer-reviewed research, as evidenced by its Q2 category designation in Pulmonary and Respiratory Medicine. BMC Pulmonary Medicine aims to foster innovation and scholarship among researchers, professionals, and students, making it an indispensable resource for anyone engaged in pulmonary research and practice. The journal, accessible to everyone, enables the dissemination of impactful research that can influence clinical practice and policy worldwide.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Fostering interdisciplinary collaboration in respiratory medicine.
Publisher: AMER THORACIC SOCISSN: 1073-449XFrequency: 24 issues/year

American Journal of Respiratory and Critical Care Medicine, published by the American Thoracic Society, is a leading scholarly journal dedicated to advancing the fields of critical care and pulmonary medicine. With an impressive impact factor and recognized in the Q1 quartile for both Critical Care and Pulmonary Medicine, this journal is essential reading for researchers, clinicians, and students invested in innovative practices and therapies in respiratory health. Through high-quality, peer-reviewed research articles, the journal addresses significant contemporary issues in respiratory and critical care, offering unparalleled insights and fostering interdisciplinary collaboration. Although the journal adheres to a traditional subscription model, it remains a cornerstone for those wishing to stay at the forefront of medical science in this vital area. With its extensive historical context since its establishment in 1991 and continuous publication spanning through 2024, the journal is committed to promoting discourse and disseminating knowledge that ultimately enhances patient care and clinical outcomes.

Annals of the American Thoracic Society

Connecting researchers and clinicians for a healthier tomorrow.
Publisher: AMER THORACIC SOCISSN: 1546-3222Frequency: 12 issues/year

Annals of the American Thoracic Society is a premier journal dedicated to advancing the field of pulmonary and respiratory medicine. Published by the American Thoracic Society, this journal offers an invaluable platform for researchers and clinicians to disseminate cutting-edge research, clinical insights, and innovative methodologies. With an impressive impact factor and ranked in the top Q1 category of its field (2023) and within the top 20 of 155 according to Scopus rankings, it is positioned as a leading force in shaping clinical practice and research directions. The journal's convergence years from 2013 to 2024 indicate a commitment to providing timely and relevant content at the forefront of pulmonary health. While not an open-access journal, it ensures broad accessibility to its significant contributions in respiratory medicine, making it an essential resource for professionals, researchers, and students alike endeavoring to deepen their understanding and improve outcomes in thoracic health.

Pulmonary Therapy

Exploring breakthroughs in respiratory medicine for a healthier tomorrow.
Publisher: SPRINGERNATUREISSN: 2364-1754Frequency: 2 issues/year

Pulmonary Therapy is a leading open-access journal published by SpringerNature, dedicated to advancing the field of pulmonary and respiratory medicine as well as respiratory care. Established in 2015 and situated in the United Kingdom, the journal has rapidly gained recognition, evidenced by its impressive Q2 quartile rankings in both the Pulmonary and Respiratory Medicine and Respiratory Care categories as of 2023. With a focus on innovative research, the journal provides a platform for the dissemination of high-quality studies that address critical issues in respiratory health. Leveraging the open access model, it ensures wide dissemination and accessibility of knowledge amongst researchers, healthcare professionals, and students, thereby fostering collaborative advancements in treatment approaches and preventive care strategies. As the field continues to evolve, Pulmonary Therapy remains committed to publishing impactful scientific contributions that shape the future of respiratory medicine.

Jornal Brasileiro de Pneumologia

Connecting researchers for a healthier tomorrow in respiratory care.
Publisher: SOC BRASILEIRA PNEUMOLOGIA TISIOLOGIAISSN: 1806-3713Frequency: 6 issues/year

Jornal Brasileiro de Pneumologia is a pivotal open-access journal in the field of Pulmonary and Respiratory Medicine, published by SOC BRASILEIRA PNEUMOLOGIA TISIOLOGIA. Established in 2004, this esteemed publication has become a significant platform for researchers, health professionals, and students in Brazil and beyond, facilitating the exchange of innovative ideas and vital research findings. The journal is indexed in Scopus and is recognized in the 2023 category quartiles as Q3, ranking 86 out of 155 in its field with a corresponding 44th percentile. This reflects its growing influence and commitment to advancing knowledge concerning respiratory health. With a mission to disseminate high-quality research, the journal aims to foster advancements in clinical practice and improve outcomes in pulmonary diseases, making it an essential resource for those dedicated to enhancing the quality of care in respiratory medicine. For those seeking comprehensive access to critical studies and reviews in this domain, the Jornal Brasileiro de Pneumologia remains an invaluable asset.

AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY

Shaping the landscape of lung physiology research.
Publisher: AMER PHYSIOLOGICAL SOCISSN: 1040-0605Frequency: 12 issues/year

AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, published by the American Physiological Society, stands as a prominent peer-reviewed journal dedicated to advancing the field of lung cellular and molecular physiology. With an impressive impact factor, the journal serves as a crucial platform for disseminating high-quality research focused on the intricate mechanisms underlying pulmonary function and disease. Established in 1989, this journal has consistently ranked within the top quartiles across various categories, including Q1 in Physiology and Pulmonary and Respiratory Medicine, highlighting its significance in the scientific community. The journal covers a wide scope of topics pertinent to cell biology and physiology, catering to the needs of researchers, professionals, and students seeking to explore and contribute to this vital area of study. Although currently not offering open access, it provides comprehensive access options for subscribers, ensuring that vital research is communicated effectively to the global scientific community. With a commitment to fostering innovation and inspiring future studies, the AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY remains an essential resource for those engaged in lung research.